Marshall Wace’s Kite Pharma, Inc. KITE Stock Holding History

Marshall Wace’s Portfolio KITE Stock Details KITE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-27,239	Closed	-$4.9M	–	530
2017 Q3	$4.9M	Buy	+27,239	New	+$3.8M	0.23%	98
2016 Q4	–	Sell	-10,349	Closed	-$578K	–	1224
2016 Q3	$578K	Sell	10,349 -82,701	-89%	-$4.61M	﹤0.01%	788
2016 Q2	$4.65M	Buy	93,050 +82,616	+792%	+$4.06M	0.04%	406
2016 Q1	$479K	Sell	10,434 -166,877	-94%	-$8.08M	﹤0.01%	855
2015 Q4	$10.9M	Buy	+177,311	New	+$12.5M	0.1%	211
2015 Q3	–	Sell	-30,285	Closed	-$1.85M	–	1160
2015 Q2	$1.85M	Buy	+30,285	New	+$1.73M	0.02%	492

Marshall Wace's KITE Position: Q4 2017 in Review

Marshall Wace sold out of Kite Pharma, Inc. (KITE) in Q4 2017, closing a stake of 27,239 shares — an estimated $4.9M sold.

Marshall Wace first reported a position in KITE in Q2 2015 and held it in 6 quarters. The position peaked at $10.9M in Q4 2015. 0 funds tracked by Wall St. Rank hold KITE as of Q4 2017.

Marshall Wace reported no remaining Kite Pharma, Inc. position as of Q4 2017 after selling out during the quarter.
Marshall Wace sold 27,239 Kite Pharma, Inc. shares in Q4 2017, an estimated $4.9M.
Marshall Wace first reported a position in Kite Pharma, Inc. in Q2 2015 and held it in 6 quarters.
Marshall Wace's Kite Pharma, Inc. position peaked at $10.9M in Q4 2015.
0 funds tracked by Wall St. Rank held Kite Pharma, Inc. as of Q4 2017.

Based on Marshall Wace's 13F filing for Q4 2017, filed 14 Feb 2018.